Skip to main content
Top
Published in: Rheumatology International 4/2007

01-02-2007 | Case Report

Coexistence of systemic sclerosis with other autoimmune diseases

Authors: Paola Caramaschi, Domenico Biasi, Alessandro Volpe, Antonio Carletto, Melissa Cecchetto, Lisa Maria Bambara

Published in: Rheumatology International | Issue 4/2007

Login to get access

Abstract

To evaluate the coexistence of additional autoimmune disease in a population of patients suffering from systemic sclerosis. The record-charts of 118 Italian patients affected by systemic sclerosis (12 men, 106 women, mean age of 57.2 years, mean duration of disease 8.7 years) followed by a single centre were reviewed; any other diagnose of autoimmune disease the patient was given was recorded. Thirty-eight scleroderma patients (32.2%) were affected by one or two concomitant autoimmune diseases, for a total of 42 diagnoses. The most represented associated autoimmune diseases were autoimmune thyroiditis (17 cases) and primary Sjögren’s syndrome (10 cases). Both pulmonary fibrosis as diagnosed by chest X-ray and the extension of skin involvement evaluated by Rodnan total skin score were not correlated with an increased incidence of an additional autoimmune disorder. Our study shows that approximately one third of patients affected by systemic sclerosis developed one or more additional autoimmune diseases. Therefore patients with systemic sclerosis should be carefully evaluated both at onset and during the follow-up for the possible coexistence of other autoimmune disorders.
Literature
1.
go back to reference Harris ML, Rosen A (2003) Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 15:778–784PubMedCrossRef Harris ML, Rosen A (2003) Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 15:778–784PubMedCrossRef
3.
go back to reference Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjögren’s syndrome. Ann Rheum Dis 64:1062–1064PubMedCrossRef Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjögren’s syndrome. Ann Rheum Dis 64:1062–1064PubMedCrossRef
4.
go back to reference McDonagh JE, Isenberg DA (2000) Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 59:230–232PubMedCrossRef McDonagh JE, Isenberg DA (2000) Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 59:230–232PubMedCrossRef
5.
go back to reference Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980). Arthritis Rheum 23:581–590 Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980). Arthritis Rheum 23:581–590
6.
go back to reference LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
7.
go back to reference Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR (2002) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 21(29):S5–S8 Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR (2002) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 21(29):S5–S8
8.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
9.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef
10.
go back to reference Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344–347, 403–407 Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344–347, 403–407
11.
go back to reference Rodriguez-Reyna TS, Alarcon-Segovia D (2005) Overlap syndromes in the context of shared autoimmunity. Autoimmunity 38:219–223PubMedCrossRef Rodriguez-Reyna TS, Alarcon-Segovia D (2005) Overlap syndromes in the context of shared autoimmunity. Autoimmunity 38:219–223PubMedCrossRef
12.
go back to reference Forzati B, Mazziotti G, Cuomo G, Ressa M, Sorvillo F, Amato G, La Montagna G, Carella C, Valentini G (2005) Hashimoto’s thyroiditis is associated with peripheral lymphocyte activation in patients with systemic sclerosis. Clin Exp Rheumatol 23:43–49 Forzati B, Mazziotti G, Cuomo G, Ressa M, Sorvillo F, Amato G, La Montagna G, Carella C, Valentini G (2005) Hashimoto’s thyroiditis is associated with peripheral lymphocyte activation in patients with systemic sclerosis. Clin Exp Rheumatol 23:43–49
13.
go back to reference Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K (2003) Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis. Clin Exp Rheumatol 21:91–94PubMed Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K (2003) Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis. Clin Exp Rheumatol 21:91–94PubMed
14.
go back to reference Gomez-Puerta JA, Gil V, Cervera R, Miquel R, Jimenez S, Ramos-Casals M, Font J (2004) Coeliac disease associated with systemic sclerosis. Ann Rheum Dis 63:104–105PubMedCrossRef Gomez-Puerta JA, Gil V, Cervera R, Miquel R, Jimenez S, Ramos-Casals M, Font J (2004) Coeliac disease associated with systemic sclerosis. Ann Rheum Dis 63:104–105PubMedCrossRef
15.
go back to reference Sarkar K, Miller FW (2004) Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev 3:454–463PubMedCrossRef Sarkar K, Miller FW (2004) Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev 3:454–463PubMedCrossRef
16.
go back to reference Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, Lucchi S, Meroni PL, Marasini B, Zeni S, Watnik M, Grati FR, Simoni G, Gershwin ME, Podda M (2005) X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175:575–578PubMed Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, Lucchi S, Meroni PL, Marasini B, Zeni S, Watnik M, Grati FR, Simoni G, Gershwin ME, Podda M (2005) X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175:575–578PubMed
Metadata
Title
Coexistence of systemic sclerosis with other autoimmune diseases
Authors
Paola Caramaschi
Domenico Biasi
Alessandro Volpe
Antonio Carletto
Melissa Cecchetto
Lisa Maria Bambara
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2007
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0207-3

Other articles of this Issue 4/2007

Rheumatology International 4/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.